Skip to main content
Top
Published in: Tumor Biology 12/2016

01-12-2016 | Retraction Note

Retraction Note to: Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology

Authors: Ehsan Hosseini, Behnam Pedram, Ali Mohammad Bahrami, Seyed Rashid Touni, Hamed Zamankhan Malayeri, Aram Mokarizadeh, Mehdi Pourzaer, Maryam Pourzaer, Shahram Zehtabian, Sheida Mohajer, Sharareh Ahmadi

Published in: Tumor Biology | Issue 12/2016

Login to get access

Excerpt

Retraction Note to: Tumor Biol (2015) 36:929–937
Metadata
Title
Retraction Note to: Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology
Authors
Ehsan Hosseini
Behnam Pedram
Ali Mohammad Bahrami
Seyed Rashid Touni
Hamed Zamankhan Malayeri
Aram Mokarizadeh
Mehdi Pourzaer
Maryam Pourzaer
Shahram Zehtabian
Sheida Mohajer
Sharareh Ahmadi
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 12/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5474-3

Other articles of this Issue 12/2016

Tumor Biology 12/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine